These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 32247367)

  • 1. Endosomal sorting pathways in the pathogenesis of Parkinson's disease.
    Cunningham LA; Moore DJ
    Prog Brain Res; 2020; 252():271-306. PubMed ID: 32247367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRRK2 and the Endolysosomal System in Parkinson's Disease.
    Erb ML; Moore DJ
    J Parkinsons Dis; 2020; 10(4):1271-1291. PubMed ID: 33044192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the endolysosomal system in Parkinson's disease.
    Vidyadhara DJ; Lee JE; Chandra SS
    J Neurochem; 2019 Sep; 150(5):487-506. PubMed ID: 31287913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations.
    Rivero-Ríos P; Romo-Lozano M; Fernández B; Fdez E; Hilfiker S
    Cells; 2020 Jul; 9(7):. PubMed ID: 32709066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson's Disease.
    Nguyen M; Wong YC; Ysselstein D; Severino A; Krainc D
    Trends Neurosci; 2019 Feb; 42(2):140-149. PubMed ID: 30509690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila.
    Inoshita T; Arano T; Hosaka Y; Meng H; Umezaki Y; Kosugi S; Morimoto T; Koike M; Chang HY; Imai Y; Hattori N
    Hum Mol Genet; 2017 Aug; 26(15):2933-2948. PubMed ID: 28482024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
    Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
    Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VPS35, the Retromer Complex and Parkinson's Disease.
    Williams ET; Chen X; Moore DJ
    J Parkinsons Dis; 2017; 7(2):219-233. PubMed ID: 28222538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Parkinson's disease related mutant VPS35 (D620N) amplifies the LRRK2 response to endolysosomal stress.
    McCarron KR; Elcocks H; Mortiboys H; Urbé S; Clague MJ
    Biochem J; 2024 Feb; 481(4):265-278. PubMed ID: 38299383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endosomal traffic and glutamate synapse activity are increased in VPS35 D620N mutant knock-in mouse neurons, and resistant to LRRK2 kinase inhibition.
    Kadgien CA; Kamesh A; Milnerwood AJ
    Mol Brain; 2021 Sep; 14(1):143. PubMed ID: 34530877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VPS35 and retromer dysfunction in Parkinson's disease.
    Rowlands J; Moore DJ
    Philos Trans R Soc Lond B Biol Sci; 2024 Apr; 379(1899):20220384. PubMed ID: 38368930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of
    Sargent D; Moore DJ
    Int Rev Mov Disord; 2021; 2():221-244. PubMed ID: 35497708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson's disease.
    Nguyen M; Krainc D
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5576-5581. PubMed ID: 29735704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endosomal dysfunction in iPSC-derived neural cells from Parkinson's disease patients with VPS35 D620N.
    Bono K; Hara-Miyauchi C; Sumi S; Oka H; Iguchi Y; Okano HJ
    Mol Brain; 2020 Oct; 13(1):137. PubMed ID: 33032646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Synuclein and the Endolysosomal System in Parkinson's Disease: Guilty by Association.
    Teixeira M; Sheta R; Idi W; Oueslati A
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease.
    Taylor M; Alessi DR
    Curr Opin Cell Biol; 2020 Apr; 63():102-113. PubMed ID: 32036294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Vps35 D620N mutation linked to Parkinson's disease disrupts the cargo sorting function of retromer.
    Follett J; Norwood SJ; Hamilton NA; Mohan M; Kovtun O; Tay S; Zhe Y; Wood SA; Mellick GD; Silburn PA; Collins BM; Bugarcic A; Teasdale RD
    Traffic; 2014 Feb; 15(2):230-44. PubMed ID: 24152121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease mechanisms as subtypes: Lysosomal dysfunction in the endolysosomal Parkinson's disease subtype.
    Mamais A; Wallings R; Rocha EM
    Handb Clin Neurol; 2023; 193():33-51. PubMed ID: 36803821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endosomal Trafficking in Alzheimer's Disease, Parkinson's Disease, and Neuronal Ceroid Lipofuscinosis.
    Qureshi YH; Baez P; Reitz C
    Mol Cell Biol; 2020 Sep; 40(19):. PubMed ID: 32690545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on the Interplay between LRRK2, Rab GTPases and Parkinson's Disease.
    Komori T; Kuwahara T
    Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.